We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01520220
First Posted: January 27, 2012
Last Update Posted: April 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Eli Lilly and Company
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 24, 2017
  Primary Completion Date: June 26, 2015 (Final data collection date for primary outcome measure)